stockrow
Friday 6 November 2026
Export AMN’s income statement to Excel — free account
AMN Healthcare Services Inc
AMN Healthcare Medical Care Facilities
AMN Healthcare Services Inc’s revenue for fiscal 2025 (year ended December 2025) was $2.7 billion, down 8.49% from fiscal 2024.
- Revenue
- +13.1%
- EPS
- +11.8%
- Free cash flow
- −759.5%
- Total debt
- −18.9%
Quarter to September 2026, against a year earlier
36.15
11.27
−23.77%
Follow AMN
Alert me
| Older periods | Dec '25 | Mar '26 | Jun '26 | Sep '26 From the 10-Q filed 6 Nov | |
|---|---|---|---|---|---|
P/E ratio |
+8 more quarters Free account |
0.00 | 0.00 | 11.99 | 12.86 |
P/S ratio |
0.22 | 0.21 | 0.37 | 0.40 | |
P/FCF ratio |
2.62 | 1.01 | 2.89 | 4.32 | |
P/Operating CF |
8.03 | 1.27 | (6.65) | (16.03) | |
P/B ratio |
0.95 | 1.00 | 1.70 | 1.81 | |
Price to Tangible BV |
0.00 | 0.00 | 0.00 | 0.00 | |
EV/Sales |
0.49 | 0.26 | 0.48 | 0.54 | |
EV/EBITDA |
6.36 | 2.88 | 4.75 | 5.46 | |
EV/Operating CF |
4.97 | 1.21 | 3.49 | 5.24 | |
EV/FCF |
5.77 | 1.27 | 3.76 | 5.82 | |
Quick Ratio |
0.80 | 0.96 | 1.02 | 0.38 | |
Current Ratio |
0.94 | 1.09 | 1.13 | 1.21 | |
Net Debt/EBITDA |
16.17 | 1.19 | 6.25 | 0.00 | |
Debt/Assets |
36.63% | 28.51% | 31.43% | 0.00% | |
Debt/Equity |
1.19 | 1.04 | 1.00 | 0.00 | |
Asset Turnover |
1.21 | 1.37 | 1.50 | 1.59 | |
Operating CF/Net income |
(9.82) | 9.05 | (8.98) | (2.62) | |
Capex/Depreciation |
(0.21) | (0.20) | (0.27) | 0.00 | |
Interest Coverage |
0.66 | 17.46 | 3.84 | 6.89 | |
Research and Development Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Selling, General and Administrative Expense of Revenue |
20.33% | 15.85% | 21.89% | 20.81% | |
Intangible Assets out of Total Assets |
0.50 | 0.39 | 0.43 | 0.43 | |
Share Based Compensation of Revenue |
0.77% | 0.72% | 1.46% | 1.19% | |
Graham Net Nets |
(1.49) | (1.06) | (0.60) | (0.51) | |
Graham Number |
0.00 | 0.00 | 33.97 | 35.27 | |
Earnings Yield |
(15.80%) | (4.69%) | 8.34% | 7.78% | |
Free Cash Flow Yield |
38.24% | 98.76% | 34.59% | 23.15% | |
Revenue per Share |
19.42 | 35.43 | 17.25 | 18.34 | |
Operating CF per Share |
1.96 | 14.46 | (4.87) | (2.24) | |
Capex per Share |
(0.21) | (0.19) | (0.23) | (0.25) | |
Free Cash Flow per Share |
1.76 | 14.27 | (5.10) | (2.49) | |
Cash per Share |
0.88 | 14.41 | 9.27 | 6.55 | |
Shareholders Equity per Share |
16.67 | 18.32 | 19.00 | 19.82 | |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Book value per Share |
16.67 | 18.32 | 19.00 | 19.82 | |
Free Cash Flow |
67.63 | 555.21 | (198.97) | (97.33) | |
Working Capital |
(32.24) | 92.33 | 98.77 | 137.95 | |
Capital Expenditures |
(7.95) | (7.25) | (9.04) | (9.81) | |
Net Current Asset Value |
(906.62) | (755.05) | (753.44) | (714.23) | |
EV/EBIT |
0.00 | 18.20 | 8.23 | 9.32 | |
Capex to Sales |
0.01 | 0.01 | 0.01 | 0.01 | |
Price to Operating Income |
0.00 | 14.50 | 6.32 | 6.92 | |
| Other line items | |||||
Average Receivables |
469.45 | 464.67 | 435.77 | — | |
Average Payables |
173.14 | 196.68 | 184.42 | 180.53 | |
Average Assets |
2,254.92 | 2,499.75 | 2,288.10 | 2,215.96 | |
Average Common Equity |
674.36 | 713.93 | 674.44 | 709.71 |
Columns are period end dates · fundamentals updated 6 Nov 2026